When should codeine be prescribed for cough?

When Should Codeine Be Given for Cough?

Codeine should NOT be routinely prescribed for acute viral cough or upper respiratory infections, but may be considered for chronic bronchitis when short-term symptomatic relief is needed and other measures have failed, or for palliative care in severe refractory cough (particularly in lung cancer patients). 1, 2, 3

Key Clinical Algorithm

For Acute Cough (< 3 weeks)

Do NOT prescribe codeine. 1

• Acute viral cough is self-limited and benign
• Codeine has no greater efficacy than dextromethorphan but carries a significantly worse adverse effect profile 1
• Central cough suppressants including codeine have limited efficacy for URI-related cough and are not recommended 2, 3
• First-line: Simple home remedies (honey and lemon), dextromethorphan (60 mg for maximum effect), or menthol inhalation 1

For Postinfectious Cough (3-8 weeks)

Reserve codeine as a last resort only when other measures fail. 2

• Try first: Inhaled ipratropium bromide (Grade B evidence) 2
• If persistent and affecting quality of life: Inhaled corticosteroids 2
• For severe paroxysms: Short course of prednisone 30-40 mg daily 2
• Only after these fail: Consider codeine or dextromethorphan 2

For Chronic Bronchitis

Codeine may be prescribed for short-term symptomatic relief. 2, 3

• Evidence level: Fair, Grade B recommendation 3
• Use only for short-term relief of coughing 2, 3
• Typical dosing: 30-60 mg four times daily 4
• Monitor closely for adverse effects (constipation, sedation, dependence risk)

For Palliative Care/Lung Cancer

Codeine is appropriate for refractory cough in palliative patients. 4, 5

• Use when cough persists despite treating underlying causes
• Bedtime dosing (30-60 mg) may help suppress cough and improve sleep 4
• Important caveat: Codeine is actually less preferred than other opioids (pholcodine, hydrocodone, dihydrocodeine, or morphine) due to its greater side effect profile 4
• If already on morphine for other symptoms, increase dose by 20% rather than adding codeine 4

Critical Safety Warnings

Absolute Contraindications

• Children under 12 years: Risk of fatal respiratory depression, especially in ultra-rapid CYP2D6 metabolizers 6
• Obese children: Even weight-adjusted doses have caused deaths 6
• Breastfeeding mothers: Codeine metabolites pass into breast milk 7

High-Risk Situations Requiring Caution

• Chronic pulmonary disease or baseline shortness of breath 7
• Patients on other CNS depressants
• Persistent cough with excessive phlegm (may indicate need for different treatment) 7
• Smoking, asthma, chronic bronchitis, or emphysema (investigate underlying cause first) 7

Duration Limits

• Maximum 7 days for symptomatic treatment 7
• If no improvement within 7 days, stop and reassess - may indicate serious underlying condition 7
• Real-world data shows 14% of patients receive codeine for >8 weeks, which is excessive and not evidence-based 8

Common Pitfalls to Avoid

1. Prescribing for acute viral cough: This is the most common error - codeine offers no benefit over cheaper, safer alternatives 1, 2

2. Assuming patient expectations require opioids: Studies show patients do not necessarily expect or require opioid prescriptions, and education can dramatically reduce prescribing without increasing complaints 9

3. Using subtherapeutic doses: Many over-the-counter preparations contain codeine at doses too low to be effective 1

4. Ignoring addiction risk: Codeine carries significant dependence potential, and prescribers often underestimate this risk 9

5. Failing to address underlying causes: Codeine should never substitute for proper diagnosis and treatment of conditions like asthma, GERD, or upper airway cough syndrome 2

Practical Dosing When Indicated

From FDA labeling 7:

• Adults and children ≥12 years: 10 mL (containing codeine) every 4 hours
• Children 6-11 years: 5 mL every 4 hours
• Children <6 years: Consult physician (generally contraindicated)
• Maximum: 6 doses in 24 hours

However, given safety concerns, codeine should generally be avoided in all pediatric patients. 6

The Bottom Line

The evidence strongly suggests codeine is overprescribed and overvalued as an antitussive. 1, 8, 9 Its role should be limited to chronic bronchitis requiring short-term symptomatic relief and palliative care situations where other options have failed. For most cough presentations, safer and equally effective alternatives exist.